Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Radhika Kainthla

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Anti-Cancer Drugs|July 9, 2016
Adjuvant chemotherapy for ypT0N0M0 rectal cancer following chemoradiotherapy and total mesorectal excisionRadhika Kainthla, Sergio Huerta
Blood|December 8, 2022
Dinner-plate nuclei in hypogranular acute promyelocytic leukemiaMohammad Faizan Zahid, Radhika Kainthla
Leukemia & Lymphoma|October 9, 2023
Sustained long-term remission with tyrosine kinase inhibitor therapy in treatment-refractory B-cell acute lymphoblastic leukemia harboring a <i>RCSD1::ABL2</i> fusion geneMohammad Faizan Zahid, Radhika Kainthla
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|April 24, 2014
DabrafenibRadhika Kainthla, Kevin B Kim, Gerald S Falchook
Pharmacogenomics and Personalized Medicine|February 12, 2014
Dabrafenib for treatment of BRAF-mutant melanomaRadhika Kainthla, Kevin B Kim, Gerald S Falchook
Nature Communications|July 1, 2025
Dual TIGIT and PD-1 blockade with domvanalimab plus zimberelimab in hepatocellular carcinoma refractory to anti-PD-1 therapies: the phase 2 LIVERTI trialDavid Hsiehchen, Radhika Kainthla, Heather Kline, et al.
European Journal of Haematology|December 29, 2023
Outcomes in Kaposi's sarcoma-associated herpesvirus -associated primary effusion lymphoma and multicentric Castleman's disease in patients with human immunodeficiency virus (HIV) in a safety-net hospital systemMelanie Lopez, Radhika Kainthla, Susana Lazarte, et al.
AIDS (London, England)|December 21, 2021
Mortality disparities among patients with HIV-associated Kaposi's sarcoma in the southern United StatesSheena M Knights, Susana M Lazarte, Radhika Kainthla, et al.
Acta Haematologica|September 9, 2025
Patient Characteristics and Outcomes of Nodular Lymphocyte-Predominant Hodgkin's Lymphoma at a Safety-Net System Compared to an Academic Comprehensive Cancer CenterLuise Froessl, Theo Sottero, L Steven Brown, et al.
Cell Reports|April 9, 2013
Regulation of telomerase alternative splicing: a target for chemotherapyMandy S Wong, Ling Chen, Christopher Foster, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Anti-Cancer Drugs|July 9, 2016
Adjuvant chemotherapy for ypT0N0M0 rectal cancer following chemoradiotherapy and total mesorectal excisionRadhika Kainthla, Sergio Huerta
Blood|December 8, 2022
Dinner-plate nuclei in hypogranular acute promyelocytic leukemiaMohammad Faizan Zahid, Radhika Kainthla
Leukemia & Lymphoma|October 9, 2023
Sustained long-term remission with tyrosine kinase inhibitor therapy in treatment-refractory B-cell acute lymphoblastic leukemia harboring a <i>RCSD1::ABL2</i> fusion geneMohammad Faizan Zahid, Radhika Kainthla
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|April 24, 2014
DabrafenibRadhika Kainthla, Kevin B Kim, Gerald S Falchook
Pharmacogenomics and Personalized Medicine|February 12, 2014
Dabrafenib for treatment of BRAF-mutant melanomaRadhika Kainthla, Kevin B Kim, Gerald S Falchook
Nature Communications|July 1, 2025
Dual TIGIT and PD-1 blockade with domvanalimab plus zimberelimab in hepatocellular carcinoma refractory to anti-PD-1 therapies: the phase 2 LIVERTI trialDavid Hsiehchen, Radhika Kainthla, Heather Kline, et al.
European Journal of Haematology|December 29, 2023
Outcomes in Kaposi's sarcoma-associated herpesvirus -associated primary effusion lymphoma and multicentric Castleman's disease in patients with human immunodeficiency virus (HIV) in a safety-net hospital systemMelanie Lopez, Radhika Kainthla, Susana Lazarte, et al.
AIDS (London, England)|December 21, 2021
Mortality disparities among patients with HIV-associated Kaposi's sarcoma in the southern United StatesSheena M Knights, Susana M Lazarte, Radhika Kainthla, et al.
Acta Haematologica|September 9, 2025
Patient Characteristics and Outcomes of Nodular Lymphocyte-Predominant Hodgkin's Lymphoma at a Safety-Net System Compared to an Academic Comprehensive Cancer CenterLuise Froessl, Theo Sottero, L Steven Brown, et al.
Cell Reports|April 9, 2013
Regulation of telomerase alternative splicing: a target for chemotherapyMandy S Wong, Ling Chen, Christopher Foster, et al.
Pageof 3